Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Topical and intralesional therapies for in-transitmelanoma.

Henderson MA.

Melanoma Manag. 2019 Sep 2;6(3):MMT23. doi: 10.2217/mmt-2019-0008. Review.

2.

PTPN2 phosphatase deletion in T cells promotes anti-tumour immunity and CAR T-cell efficacy in solid tumours.

Wiede F, Lu KH, Du X, Liang S, Hochheiser K, Dodd GT, Goh PK, Kearney C, Meyran D, Beavis PA, Henderson MA, Park SL, Waithman J, Zhang S, Zhang ZY, Oliaro J, Gebhardt T, Darcy PK, Tiganis T.

EMBO J. 2020 Jan 15;39(2):e103637. doi: 10.15252/embj.2019103637. Epub 2019 Dec 5.

3.

Pre-operative β-blockade with propranolol reduces biomarkers of metastasis in breast cancer: a Phase II randomized trial.

Hiller JG, Cole SW, Crone EM, Byrne DJ, Shackleford DM, Pang JB, Henderson MA, Nightingale SS, Ho KM, Myles PS, Fox S, Riedel B, Sloan EK.

Clin Cancer Res. 2019 Nov 21. pii: clincanres.2641.2019. doi: 10.1158/1078-0432.CCR-19-2641. [Epub ahead of print]

PMID:
31754048
4.

The Prognosis and Natural History of In-Transit Melanoma Metastases at a High-Volume Centre.

Nan Tie E, Na LH, Hicks RJ, Spillane J, Speakman D, Henderson MA, Gyorki DE.

Ann Surg Oncol. 2019 Dec;26(13):4673-4680. doi: 10.1245/s10434-019-07965-w. Epub 2019 Oct 22.

PMID:
31641949
5.

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.

House IG, Savas P, Lai J, Chen AXY, Oliver AJ, Teo ZL, Todd KL, Henderson MA, Giuffrida L, Petley EV, Sek K, Mardiana S, Gide TN, Quek C, Scolyer RA, Long GV, Wilmott JS, Loi S, Darcy PK, Beavis PA.

Clin Cancer Res. 2020 Jan 15;26(2):487-504. doi: 10.1158/1078-0432.CCR-19-1868. Epub 2019 Oct 21.

6.

New treatment paradigms for clinically apparent metastatic melanoma in regional lymph nodes.

Henderson MA, Spillane J, Hughes TM, Spillane AJ, Smithers BM, Thompson JF.

ANZ J Surg. 2019 Oct;89(10):1187-1189. doi: 10.1111/ans.15407. No abstract available.

PMID:
31621166
7.

Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of Life.

Henderson MA, Gyorki D, Burmeister BH, Ainslie J, Fisher R, Di Iulio J, Smithers BM, Hong A, Shannon K, Scolyer RA, Carruthers S, Coventry BJ, Babington S, Duprat J, Hoekstra HJ, Thompson JF.

Ann Surg Oncol. 2019 Dec;26(13):4663-4672. doi: 10.1245/s10434-019-07810-0. Epub 2019 Sep 12.

PMID:
31515719
8.

A review of the influence of mammographic density on breast cancer clinical and pathological phenotype.

Shawky MS, Huo CW, Henderson MA, Redfern A, Britt K, Thompson EW.

Breast Cancer Res Treat. 2019 Sep;177(2):251-276. doi: 10.1007/s10549-019-05300-1. Epub 2019 Jun 8. Review.

PMID:
31177342
9.

Negative Sentinel Lymph Node Biopsy in Patients with Melanoma: The Patient's Perspective.

Banting S, Milne D, Thorpe T, Na L, Spillane J, Speakman D, Henderson MA, Gyorki DE.

Ann Surg Oncol. 2019 Jul;26(7):2263-2267. doi: 10.1245/s10434-019-07375-y. Epub 2019 Apr 22.

PMID:
31011899
10.

Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.

Miura JT, Kroon HM, Beasley GM, Mullen D, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Kim Y, Naqvi SMH, Potdar A, Daou H, Sun J, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Mark Smithers B, Coventry BJ, Tyler DS, Thompson JF, Zager JS.

Ann Surg Oncol. 2019 Aug;26(8):2486-2494. doi: 10.1245/s10434-019-07288-w. Epub 2019 Mar 25.

PMID:
30911949
11.

Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study.

Kroon HM, Coventry BJ, Henderson MA, Barbour A, Serpell J, Smithers BM, Thompson JF.

Eur J Surg Oncol. 2019 May;45(5):832-837. doi: 10.1016/j.ejso.2019.02.026. Epub 2019 Feb 27.

PMID:
30867095
12.

Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA.

Tan L, Sandhu S, Lee RJ, Li J, Callahan J, Ftouni S, Dhomen N, Middlehurst P, Wallace A, Raleigh J, Hatzimihalis A, Henderson MA, Shackleton M, Haydon A, Mar V, Gyorki DE, Oudit D, Dawson MA, Hicks RJ, Lorigan P, McArthur GA, Marais R, Wong SQ, Dawson SJ.

Ann Oncol. 2019 May 1;30(5):804-814. doi: 10.1093/annonc/mdz048.

PMID:
30838379
13.

Accuracy of partial biopsies in the management of cutaneous melanoma.

Doolan BJ, Robinson AJ, Wolfe R, Kelly JW, McLean C, McCormack C, Henderson MA, Pan Y.

Australas J Dermatol. 2019 Aug;60(3):209-213. doi: 10.1111/ajd.13004. Epub 2019 Feb 17.

PMID:
30773625
14.

Management of in-transit melanoma metastases: a review.

Nan Tie E, Henderson MA, Gyorki DE.

ANZ J Surg. 2019 Jun;89(6):647-652. doi: 10.1111/ans.14921. Epub 2018 Nov 9. Review.

PMID:
30414233
15.

Radiation Dose and Fractionation for Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Practice Patterns.

Farrell MJ, Yahya JB, Degnin C, Chen Y, Holland JM, Henderson MA, Jaboin JJ, Harkenrider MM, Thomas CR Jr, Mitin T.

Clin Lung Cancer. 2019 Jan;20(1):13-19. doi: 10.1016/j.cllc.2018.08.015. Epub 2018 Aug 22.

PMID:
30219240
16.

High mammographic density in women is associated with protumor inflammation.

Huo CW, Hill P, Chew G, Neeson PJ, Halse H, Williams ED, Henderson MA, Thompson EW, Britt KL.

Breast Cancer Res. 2018 Aug 9;20(1):92. doi: 10.1186/s13058-018-1010-2.

17.

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma.

Halse H, Colebatch AJ, Petrone P, Henderson MA, Mills JK, Snow H, Westwood JA, Sandhu S, Raleigh JM, Behren A, Cebon J, Darcy PK, Kershaw MH, McArthur GA, Gyorki DE, Neeson PJ.

Sci Rep. 2018 Jul 24;8(1):11158. doi: 10.1038/s41598-018-28944-3.

18.

Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3- Cell-Mediated Modulation of CD103+ Dendritic Cells.

Beavis PA, Henderson MA, Giuffrida L, Davenport AJ, Petley EV, House IG, Lai J, Sek K, Milenkovski N, John LB, Mardiana S, Slaney CY, Trapani JA, Loi S, Kershaw MH, Haynes NM, Darcy PK.

Cancer Immunol Res. 2018 Sep;6(9):1069-1081. doi: 10.1158/2326-6066.CIR-18-0291. Epub 2018 Jul 17.

19.

Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.

Moncrieff MD, Gyorki D, Saw R, Spillane AJ, Thompson JF, Peach H, Oudit D, Geh J, Dziewulsk P, Wilson E, Matteucci P, Pritchard-Jones R, Olofsson Bagge R, Wright FC, Crampton N, Cassell O, Jallali N, Berger A, Kelly J, Hamilton S, Durrani A, Lo S, Paton E, Henderson MA.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):991. doi: 10.1245/s10434-018-6612-5.

20.

'Scalp coordinate system': a new tool to accurately describe cutaneous lesions on the scalp: a pilot study.

Alexander W, Miller G, Alexander P, Henderson MA, Webb A.

ANZ J Surg. 2019 Apr;89(4):E127-E131. doi: 10.1111/ans.14692. Epub 2018 Jun 12.

PMID:
29895097
21.

Timing of Thoracic Radiation Therapy With Chemotherapy in Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.

Farrell MJ, Yahya JB, Degnin C, Chen Y, Holland JM, Henderson MA, Jaboin JJ, Harkenrider MM, Thomas CR Jr, Mitin T.

Clin Lung Cancer. 2018 Nov;19(6):e815-e821. doi: 10.1016/j.cllc.2018.04.007. Epub 2018 May 5.

PMID:
29857969
22.

1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.

Moncrieff MD, Gyorki D, Saw R, Spillane AJ, Thompson JF, Peach H, Oudit D, Geh J, Dziewulski P, Wilson E, Matteucci P, Pritchard-Jones R, Olofsson Bagge R, Wright FC, Crampton N, Cassell O, Jallali N, Berger A, Kelly J, Hamilton S, Durrani A, Lo S, Paton E, Henderson MA.

Ann Surg Oncol. 2018 Sep;25(9):2541-2549. doi: 10.1245/s10434-018-6470-1. Epub 2018 May 30. Erratum in: Ann Surg Oncol. 2018 Jun 26;:. Thompson JF [added].

23.

Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.

Farrell MJ, Yahya JB, Degnin C, Chen Y, Holland JM, Henderson MA, Jaboin JJ, Harkenrider MM, Thomas CR Jr, Mitin T.

Clin Lung Cancer. 2018 Jul;19(4):371-376. doi: 10.1016/j.cllc.2018.02.009. Epub 2018 Feb 23.

PMID:
29559208
24.

Restricted venous access after lymph node dissection: no evidence (voodoo).

Snow H, Riedel B, Gyorki D, Henderson MA, Speakman D.

ANZ J Surg. 2018 Mar;88(3):131-132. doi: 10.1111/ans.14277. No abstract available.

PMID:
29512340
25.

Melanoma in the very elderly, management in patients 85years of age and over.

Rees MJ, Liao H, Spillane J, Speakman D, McCormack C, Donahoe S, Pohl M, Webb A, Gyorki D, Henderson MA.

J Geriatr Oncol. 2018 Sep;9(5):488-493. doi: 10.1016/j.jgo.2018.01.001. Epub 2018 Feb 3.

PMID:
29398454
26.

Healthy by Design: Using a Gender Focus to Influence Complete Streets Policy.

Keippel AE, Henderson MA, Golbeck AL, Gallup T, Duin DK, Hayes S, Alexander S, Ciemins EL.

Womens Health Issues. 2017 Oct 17;27 Suppl 1:S22-S28. doi: 10.1016/j.whi.2017.09.005.

PMID:
29050655
27.

Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer.

Dushyanthen S, Teo ZL, Caramia F, Savas P, Mintoff CP, Virassamy B, Henderson MA, Luen SJ, Mansour M, Kershaw MH, Trapani JA, Neeson PJ, Salgado R, McArthur GA, Balko JM, Beavis PA, Darcy PK, Loi S.

Nat Commun. 2017 Sep 19;8(1):606. doi: 10.1038/s41467-017-00728-9.

28.

Subungual melanoma: Management in the modern era.

Reilly DJ, Aksakal G, Gilmour RF, Gyorki DE, Chauhan A, Webb A, Henderson MA.

J Plast Reconstr Aesthet Surg. 2017 Dec;70(12):1746-1752. doi: 10.1016/j.bjps.2017.08.001. Epub 2017 Aug 16.

PMID:
28888486
29.

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity.

Burr ML, Sparbier CE, Chan YC, Williamson JC, Woods K, Beavis PA, Lam EYN, Henderson MA, Bell CC, Stolzenburg S, Gilan O, Bloor S, Noori T, Morgens DW, Bassik MC, Neeson PJ, Behren A, Darcy PK, Dawson SJ, Voskoboinik I, Trapani JA, Cebon J, Lehner PJ, Dawson MA.

Nature. 2017 Sep 7;549(7670):101-105. doi: 10.1038/nature23643. Epub 2017 Aug 16.

30.

Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study.

Kroon HM, Coventry BJ, Giles MH, Henderson MA, Speakman D, Wall M, Barbour A, Serpell J, Paddle P, Smithers BM, Thompson JF.

Ann Surg Oncol. 2017 Oct;24(11):3245-3251. doi: 10.1245/s10434-017-6046-5. Epub 2017 Aug 10.

PMID:
28799064
31.

Importance of preoperative diagnosis for management of patients with suspected retroperitoneal sarcoma.

Gyorki DE, Choong PFM, Slavin J, Henderson MA.

ANZ J Surg. 2018 Apr;88(4):274-277. doi: 10.1111/ans.14125. Epub 2017 Aug 2. Review.

PMID:
28768365
32.

HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2+ Tumors.

Medon M, Vidacs E, Vervoort SJ, Li J, Jenkins MR, Ramsbottom KM, Trapani JA, Smyth MJ, Darcy PK, Atadja PW, Henderson MA, Johnstone RW, Haynes NM.

Cancer Res. 2017 May 15;77(10):2594-2606. doi: 10.1158/0008-5472.CAN-16-2247. Epub 2017 Mar 1.

33.

Front-of-neck access: a practical viewpoint, from experience.

Henderson MA.

Br J Anaesth. 2017 Mar 1;118(3):468. doi: 10.1093/bja/aex017. No abstract available.

34.

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy.

Beavis PA, Henderson MA, Giuffrida L, Mills JK, Sek K, Cross RS, Davenport AJ, John LB, Mardiana S, Slaney CY, Johnstone RW, Trapani JA, Stagg J, Loi S, Kats L, Gyorki D, Kershaw MH, Darcy PK.

J Clin Invest. 2017 Mar 1;127(3):929-941. doi: 10.1172/JCI89455. Epub 2017 Feb 6.

35.

A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells.

Mardiana S, John LB, Henderson MA, Slaney CY, von Scheidt B, Giuffrida L, Davenport AJ, Trapani JA, Neeson PJ, Loi S, Haynes NM, Kershaw MH, Beavis PA, Darcy PK.

Cancer Res. 2017 Mar 15;77(6):1296-1309. doi: 10.1158/0008-5472.CAN-16-1831. Epub 2017 Jan 12.

36.

Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT).

Déry JP, Mehta SR, Fisher HN, Zhang X, Zhu YE, Welsh RC, Lavi S, Cieza T, Henderson MA, Lutchmedial S, Siega AJ, Cheema AN, Wong BY, Kokis A, Dehghani P, Goodman SG; Canadian Observational AntiPlatelet sTudy (COAPT) Investigators.

Am Heart J. 2016 Nov;181:26-34. doi: 10.1016/j.ahj.2016.07.014. Epub 2016 Aug 7.

PMID:
27823690
37.

Prospective evaluation of prognostic indicators for early recurrence of cutaneous melanoma.

Matheson JA, Te Marvelde L, Mailer S, Speakman D, Spillane J, Henderson MA, Gyorki DE.

Melanoma Res. 2017 Feb;27(1):43-49. doi: 10.1097/CMR.0000000000000302.

PMID:
27753732
38.

Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy.

Sra S, Tan MK, Mehta SR, Fisher HN, Déry JP, Welsh RC, Eisenberg MJ, Overgaard CB, Rose BF, Siega AJ, Cheema AN, Wong BY, Henderson MA, Lutchmedial S, Lavi S, Goodman SG, Yan AT; Canadian Observational AntiPlatelet sTudy (COAPT) Investigators.

Am Heart J. 2016 Oct;180:82-9. doi: 10.1016/j.ahj.2016.07.015. Epub 2016 Aug 7.

PMID:
27659886
39.

Human glandular organoid formation in murine engineering chambers after collagenase digestion and flow cytometry isolation of normal human breast tissue single cells.

Huo CW, Huang D, Chew GL, Hill P, Vohora A, Ingman WV, Glynn DJ, Godde N, Henderson MA, Thompson EW, Britt KL.

Cell Biol Int. 2016 Nov;40(11):1212-1223. doi: 10.1002/cbin.10675. Epub 2016 Sep 13.

PMID:
27590622
40.

Strong Temperature Dependence in the Reactivity of H2 on RuO2(110).

Henderson MA, Dahal A, Dohnálek Z, Lyubinetsky I.

J Phys Chem Lett. 2016 Aug 4;7(15):2967-70. doi: 10.1021/acs.jpclett.6b01307. Epub 2016 Jul 20.

PMID:
27434420
41.

Light Makes a Surface Banana-Bond Split: Photodesorption of Molecular Hydrogen from RuO2(110).

Henderson MA, Mu R, Dahal A, Lyubinetsky I, Dohnálek Z, Glezakou VA, Rousseau R.

J Am Chem Soc. 2016 Jul 20;138(28):8714-7. doi: 10.1021/jacs.6b05083. Epub 2016 Jul 12.

PMID:
27390889
42.

CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to Tumorigenicity.

Boyle SE, Fedele CG, Corbin V, Wybacz E, Szeto P, Lewin J, Young RJ, Wong A, Fuller R, Spillane J, Speakman D, Donahoe S, Pohl M, Gyorki D, Henderson MA, Johnstone RW, Papenfuss AT, Shackleton M.

Cancer Res. 2016 Jul 1;76(13):3965-77. doi: 10.1158/0008-5472.CAN-15-2377. Epub 2016 Jun 20.

43.

Intralesional PV-10 for in-transit melanoma-A single-center experience.

Lippey J, Bousounis R, Behrenbruch C, McKay B, Spillane J, Henderson MA, Speakman D, Gyorki DE.

J Surg Oncol. 2016 Sep;114(3):380-4. doi: 10.1002/jso.24311. Epub 2016 May 30.

PMID:
27237868
44.

Current Patterns of Care for Patients with Extensive-Stage SCLC: Survey of U.S. Radiation Oncologists on Their Recommendations Regarding Prophylactic Cranial Irradiation.

Jain A, Luo J, Chen Y, Henderson MA, Thomas CR Jr, Mitin T.

J Thorac Oncol. 2016 Aug;11(8):1305-1310. doi: 10.1016/j.jtho.2016.04.031. Epub 2016 May 26.

45.

Frailty and one-year mortality in major intra-abdominal operations.

Li JL, Henderson MA, Revenig LM, Sweeney JF, Kooby DA, Maithel SK, Master VA, Ogan K.

J Surg Res. 2016 Jun 15;203(2):507-512.e1. doi: 10.1016/j.jss.2016.03.007. Epub 2016 Mar 22.

PMID:
27087115
46.

Excision margins and sentinel lymph node status as prognostic factors in thick melanoma of the head and neck: A retrospective analysis.

Ruskin O, Sanelli A, Herschtal A, Webb A, Dixon B, Pohl M, Donahoe S, Spillane J, Henderson MA, Gyorki DE.

Head Neck. 2016 Sep;38(9):1373-9. doi: 10.1002/hed.24444. Epub 2016 Mar 25.

PMID:
27014970
47.

Does Graded Prognostic Assessment outperform Recursive Partitioning Analysis in patients with moderate prognosis brain metastases?

Estabrook NC, Lutz ST, Johnson CS, Lo SS, Henderson MA.

CNS Oncol. 2016;5(2):69-76. doi: 10.2217/cns.15.45. Epub 2016 Mar 17.

48.

A review of antidepressant-induced urinary hesitancy: a focus on levomilnacipran ER including two case presentations(5633).

Asnis GM, Caneva E, Henderson MA.

Expert Opin Drug Saf. 2016 May;15(5):717-25. doi: 10.1517/14740338.2016.1164138. Epub 2016 Apr 1. Review.

PMID:
26967743
49.

Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions.

Rees MJ, Liao H, Spillane J, Speakman D, McCormack C, Donahoe S, Pohl M, Webb A, Gyorki D, Henderson MA.

Eur J Surg Oncol. 2016 Sep;42(9):1359-66. doi: 10.1016/j.ejso.2016.01.010. Epub 2016 Jan 23.

PMID:
26899940
50.

Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians.

Asnis GM, Thomas M, Henderson MA.

Int J Mol Sci. 2015 Dec 30;17(1). pii: E50. doi: 10.3390/ijms17010050. Review.

Supplemental Content

Loading ...
Support Center